PubMed Indexed | Fully Open Access | Immunology Journals

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Immunology

Open Access Journals

Looking to publish your next article?

Each journal in this portfolio is PubMed indexed, peer-reviewed and fully open access; aiming to serve both the academic research community and practitioner community.

The below journals have various specialties in:

  • microbes and infections
  • tumor immunology
  • immunological biomarkers
  • immunotherapies
  • basic and clinical immunology
  • immunology, immunotoxicology and toxicology
  • immunological basis of diseases
  • targets for immune based therapy and treatment protocols
  • basic immunology and physiology of the immune system in health and disease

Explore the links below to discover our range of open access journals and find the perfect home for your research.

Publishing Open Access

Taylor & Francis offers publishing options that support the needs of authors and researchers worldwide. To learn more about open access publishing, click the link below.
GO TO PUBLISHING OPTIONS

Emerging Microbes & Infections

An open access journal | 2019 Impact Factor 5.776

Emerging Microbes & Infections provides a new, integrated forum that allows for the timely dissemination of information about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.

The sheer volume and complexity of such information has gone beyond the scale and scope of existing specialty journals, and this journal is committed to bridging the gap between scientific communities in developed and developing countries where most of the emerging microbes and infections have occurred in recent years.

GO TO EMERGING MICROBES & INFECTIONS

OncoImmunology

An open access journal | 2019 Impact Factor 5.869

OncoImmunology focuses specifically on tumor immunology. As a result of recent progress in the field, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies.

There is a need for research that explores the combination of conventional anticancer therapies with immunotherapies. OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome.

GO TO ONCOIMMUNOLOGY

Immunological Medicine

An open access journal

Immunological Medicine encourages the submission of original manuscripts covering topics related to both basic and clinical immunology such as: rheumatology, allergology, oncology, hematology, cardiology, neurology, respiratory medicine, gastroenterology, nephrology, dermatology, pediatrics and other medical topics.

Many diseases and conditions, including autoimmune diseases, allergy-related diseases, infectious diseases, malignant diseases, immunodeficiency and transplantation-related conditions are associated with immunological abnormalities and require immunological approaches from various medical fields.

GO TO IMMUNOLOGICAL MEDICINE

Journal of Immunotoxicology

An open access journal | 2019 Impact Factor 2.974

Journal of Immunotoxicology provides a much needed singular forum for the international community of immunotoxicologists, immunologists and toxicologists working in academia, government, consulting and industry to both publish their original research and to stay informed with the latest research findings of their colleagues.

Research from many sub-disciplines are present in the journal, including molecular, developmental, pulmonary, regulatory, nutritional, mechanistic, wildlife, and environmental immunotoxicology, immunology, and toxicology.

GO TO JOURNAL OF IMMUNOTOXICOLOGY

ImmunoTargets and Therapy

A Dove Medical Press journal, part of Taylor & Francis Group, the Academic Publishing Division of Informa Plc

ImmunoTargets and Therapy focuses on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease are also covered.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

GO TO IMMUNOTARGETS AND THERAPY

Explore Taylor & Francis Immunology Journals

A portfolio of hybrid and fully open access publishing options. Our journals encompass broad, cross-discipline, and niche fields of study within immunology.
GO TO IMMUNOLOGY JOURNALS

Cogent Medicine

Scientifically sound, fully open access and peer-reviewed research. Cogent Medicine, part of Taylor & Francis Group, publishes experimental, translational and clinical approaches across all areas of biomedical sciences, clinical research and practice.
GO TO COGENT MEDICINE

F1000Research

F1000Research is an open research publishing platform for scientists, scholars and clinicians offering rapid publication of articles and other research outputs. All articles benefit from transparent peer-review and the inclusion of all source data.
GO TO F1000RESEARCH